Hutchinson Capital Management Pfizer Inc Transaction History

Hutchinson Capital Management

$480 Million
Q1 2025

A detailed history of Hutchinson Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Hutchinson Capital Management holds 24,096 shares of PFE stock, worth $582,882. This represents 0.13% of its overall portfolio holdings.

Number of Shares

24,096

Previous 27,246 11.56%

Holding current value

$582,882

Previous $722,000 15.51%

% of portfolio

0.13%

Previous 0.15%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$25.01 - $27.13 $78,781 - $85,459	-3,150 Reduced 11.56%	24,096 $610,000
Q4 2024 Feb 10, 2025	SELL	$24.8 - $30.19 $118,196 - $143,885	-4,766 Reduced 14.89%	27,246 $722,000
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $57,948 - $65,667	-2,092 Reduced 6.13%	32,012 $926,000
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $20,182 - $23,650	-799 Reduced 2.29%	34,104 $954,000
Q1 2024 May 06, 2024	SELL	$25.89 - $29.73 $23,741 - $27,262	-917 Reduced 2.56%	34,903 $968,000
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $34,125 - $44,325	-1,306 Reduced 3.52%	35,820 $1.03 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $13,927 - $16,279	-434 Reduced 1.16%	37,126 $1.23 Million
Q2 2023 Jul 25, 2023	SELL	$36.12 - $41.79 $76,466 - $88,469	-2,117 Reduced 5.34%	37,560 $1.38 Million
Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $4,923 - $6,410	-125 Reduced 0.31%	39,677 $1.62 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $67,885 - $88,617	-1,626 Reduced 3.92%	39,802 $2.04 Million
Q3 2022 Oct 31, 2022	BUY	$43.76 - $53.42 $2,625 - $3,205	60 Added 0.15%	41,428 $1.81 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $35,688 - $42,315	767 Added 1.89%	41,368 $2.17 Million
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $175,085 - $216,952	-3,827 Reduced 8.61%	40,601 $2.1 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $145,115 - $215,110	-3,512 Reduced 7.33%	44,428 $2.62 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $13,816 - $17,747	-352 Reduced 0.73%	47,940 $2.06 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $11,993 - $13,587	-334 Reduced 0.69%	48,292 $1.89 Million
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $53,584 - $60,432	1,600 Added 3.4%	48,626 $1.76 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $28,114 - $35,750	840 Added 1.82%	47,026 $1.73 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $1,682 - $1,974	-53 Reduced 0.11%	46,186 $1.7 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $129,516 - $157,122	-4,300 Reduced 8.51%	46,239 $1.51 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $66,142 - $94,503	-2,447 Reduced 4.62%	50,539 $1.65 Million
Q4 2019 Feb 05, 2020	BUY	$32.92 - $37.36 $132,503 - $150,374	4,025 Added 8.22%	52,986 $2.08 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $6,400 - $8,299	197 Added 0.4%	48,961 $1.76 Million
Q2 2019 Aug 06, 2019	SELL	$36.98 - $41.52 $53,362 - $59,913	-1,443 Reduced 2.87%	48,764 $2.11 Million
Q1 2019 May 06, 2019	SELL	$37.5 - $41.2 $11,962 - $13,142	-319 Reduced 0.63%	50,207 $2.13 Million
Q4 2018 Jan 30, 2019	SELL	$38.47 - $43.86 $16,349 - $18,640	-425 Reduced 0.83%	50,526 $2.21 Million
Q3 2018 Oct 31, 2018	SELL	$34.47 - $41.81 $24,611 - $29,852	-714 Reduced 1.38%	50,951 $2.25 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $14,412 - $15,364	-437 Reduced 0.84%	51,665 $1.87 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $16,763 - $17,786	-504 Reduced 0.96%	52,102 $1.89 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $1.63 Million - $1.8 Million	52,606	52,606 $1.88 Million

Others Institutions Holding PFE

# of Institutions

3,371

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $136B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hutchinson Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hutchinson Capital Management with notifications on news.

Account

Hutchinson Capital Management Pfizer Inc Transaction History